Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
Article in Clinical Immunology (May 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Clinical Immunology (May 2024)
Article in Journal of the American Society of Nephrology (July 2023)
Article in Kidney International (May 2023)